Tumor cell-intrinsic RIG-I signaling governs synergistic effects of immunogenic cancer therapies and checkpoint inhibitors in mice

Poeck H, Wintges A, Dahl S, Bassermann F, Haas T, Heidegger S (2021)

Publication Type: Journal article

Publication year: 2021

Journal

European Journal of Immunology Wiley-VCH Verlag

Book Volume: 51

Pages Range: 1531-1534

Journal Issue: 6

DOI: 10.1002/eji.202049158

Involved external institutions

Universitätsklinikum Regensburg DE Germany (DE) Technische Universität München (TUM) DE Germany (DE)

How to cite

APA:

Poeck, H., Wintges, A., Dahl, S., Bassermann, F., Haas, T., & Heidegger, S. (2021). Tumor cell-intrinsic RIG-I signaling governs synergistic effects of immunogenic cancer therapies and checkpoint inhibitors in mice. European Journal of Immunology, 51(6), 1531-1534. https://doi.org/10.1002/eji.202049158

MLA:

Poeck, Hendrik, et al. "Tumor cell-intrinsic RIG-I signaling governs synergistic effects of immunogenic cancer therapies and checkpoint inhibitors in mice." European Journal of Immunology 51.6 (2021): 1531-1534.

BibTeX: Download